| Study period | |||||||
---|---|---|---|---|---|---|---|---|
Screening | Procedure | 3 days | 1 month | 3 months | 6 months | 12 months | 24 months | |
Outpatient visit | √ |  | √ | √ | √ | √ | √ | √ |
Physical examination | √ |  | √ | √ | √ | √ | √ | √ |
Duplex examination | √ |  | √ |  | √ |  | √ | √ |
Inclusion criteria | √ |  |  |  |  |  |  |  |
Randomization |  | √ |  |  |  |  |  |  |
VCSS | √ |  |  | √ | √ | √ | √ | √ |
Quality of life score – AVVQ | √ |  |  | √ | √ | √ | √ | √ |
VAS pain score | √ | √ | √ |  |  |  |  |  |
Ecchymosis |  |  | √ | √ |  |  |  |  |
Other adverse events |  | √ | √ | √ | √ | √ | √ | √ |